磷酸化抑癌基因p16抗体

Quantity size:

0.1ml

Concentration:

1mg/ml 磷酸化抑癌基因p16抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, 磷酸化抑癌基因p16抗体a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012].

磷酸化抑癌基因p16抗体Also known as:

p-CDKN2A/p16-INK4a(Ser152); p-p16-INK4a(Ser152); cyclin-dependent kinase inhibitor 2A;CDK4I; p16-INK4; p16-INK4a; cyclin-dependent kinase 4 inhibitor A; cyclin-dependent kinase inhibitor 2A, isoform 1; Cyclin dependent kinase inhibitor 2A (p16, inhibits CDK4); cell cycle inhibitor; cyclin-dependent kinase inhibitor 2a p16Ink4a; cell cycle regulator; cyclin-dependent kinase inhibitor 2a p19Arf; cyclin-dependent kinase inhibitor 2A, isoform 2; Cdkn2a; Arf; INK4A; 磷酸化抑癌基因p16抗体MTS1; p16; p16Cdkn2a; p19ARF; CD2A1_HUMAN.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, .

●

Immunogen: KLH conjugated Synthesised phosphopeptide derived from human CDKN2A around the phosphorylation site of Ser152 [GP(p-S)DI].

●

磷酸化抑癌基因p16抗体Predicted Molecular Weight: 17kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl544Ga01免疫球蛋白G(IgG)多克隆抗体Polyclonal Antibody to Immunoglobulin G (IgG)

kl544Cp01免疫球蛋白G(IgG)多克隆抗体Polyclonal Antibody to Immunoglobulin G (IgG)

kl544Ca01免疫球蛋白G(IgG)多克隆抗体Polyclonal Antibody to Immunoglobulin G (IgG)

kl546Hu01免疫球蛋白A(IgA)多克隆抗体Polyclonal Antibody to Immunoglobulin A (IgA)

kl546Mu01免疫球蛋白A(IgA)多克隆抗体Polyclonal Antibody to Immunoglobulin A (IgA)

kl546Ra01免疫球蛋白A(IgA)多克隆抗体Polyclonal Antibody to Immunoglobulin A (IgA)

kl546Bo01免疫球蛋白A(IgA)多克隆抗体Polyclonal Antibody to Immunoglobulin A (IgA)

kl038Hu01免疫球蛋白κ(Igκ)多克隆抗体Polyclonal Antibody to Immunoglobulin Kappa (Igk)

kl038Mu01免疫球蛋白κ(Igκ)多克隆抗体Polyclonal Antibody to Immunoglobulin Kappa (Igk)

kl193Hu01溶菌酶(LZM)多克隆抗体Polyclonal Antibody to Lysozyme (LZM)

kl193Mu01溶菌酶(LZM)多克隆抗体Polyclonal Antibody to Lysozyme (LZM)

kl193Ra01溶菌酶(LZM)多克隆抗体Polyclonal Antibody to Lysozyme (LZM)

kl222Hu01突触核蛋白α(SNCα)多克隆抗体Polyclonal Antibody to Synuclein Alpha (SNCa)

kl222Mu01突触核蛋白α(SNCα)多克隆抗体Polyclonal Antibody to Synuclein Alpha (SNCa)

kl222Ra01突触核蛋白α(SNCα)多克隆抗体Polyclonal Antibody to Synuclein Alpha (SNCa)

kl939Hu01突触核蛋白γ(SNCγ)多克隆抗体Polyclonal Antibody to Synuclein Gamma (SNCg)

kl939Mu01突触核蛋白γ(SNCγ)多克隆抗体Polyclonal Antibody to Synuclein Gamma (SNCg)

kl939Ra01突触核蛋白γ(SNCγ)多克隆抗体Polyclonal Antibody to Synuclein Gamma (SNCg)

kl028Hu01红细胞生成素(EPO)多克隆抗体Polyclonal Antibody to Erythropoietin (EPO)

kl028Mu01红细胞生成素(EPO)多克隆抗体Polyclonal Antibody to Erythropoietin (EPO)

kl028Ra01红细胞生成素(EPO)多克隆抗体Polyclonal Antibody to Erythropoietin (EPO)